Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) Operating Expenses (2017 - 2025)

Neuronetics (STIM) has disclosed Operating Expenses for 9 consecutive years, with $26.7 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 1.45% to $26.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $103.7 million through Dec 2025, up 16.92% year-over-year, with the annual reading at $103.7 million for FY2025, 16.93% up from the prior year.
  • Operating Expenses for Q4 2025 was $26.7 million at Neuronetics, up from $24.4 million in the prior quarter.
  • The five-year high for Operating Expenses was $26.8 million in Q1 2025, with the low at $17.0 million in Q1 2021.
  • Average Operating Expenses over 5 years is $21.5 million, with a median of $20.8 million recorded in 2022.
  • Peak annual rise in Operating Expenses hit 46.03% in 2021, while the deepest fall reached 10.8% in 2021.
  • Over 5 years, Operating Expenses stood at $18.4 million in 2021, then increased by 17.08% to $21.5 million in 2022, then fell by 6.21% to $20.2 million in 2023, then soared by 30.53% to $26.4 million in 2024, then rose by 1.45% to $26.7 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $26.7 million, $24.4 million, and $25.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.